The allegations concerning Elon Musk’s personal use of ketamine and other substances should be viewed with caution and ...
A new study has found that adults with depression who start treatment with newer antipsychotic medications may face a higher ...
Legislation requiring healthcare professionals assess a woman for postpartum depression made it over the first hurdles last week by getting approval from Senate ...
19h
KHQA on MSNBlessing Health introduces new FDA-approved nasal spray treatment for resistant depressionUp to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...
Sooma Medical has received the approval of an investigational device exemption (IDE) from the US Food and Drug Administration ...
Ketamine has promise as a potential treatment for bipolar depression, particularly for people whose condition hasn’t ...
Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in life.
Sooma Oy secured U.S. FDA investigational device exemption approval to initiate a pivotal study of its transcranial direct ...
An abundance of data show that SSRIs, a class of drugs commonly used as antidepressants, are effective, though, like any drug, they have risks.
Johnson & Johnson is ending the phase 3 VENTURA clinical development program evaluating aticaprant, a selective kappa receptor antagonist, as an adjunctive treatment for major depressive disorder (MDD ...
Donald Trump and Elon Musk’s biographer, Seth Abramson, took to X/Twitter, warning that the Tesla boss is off the rails. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results